Ovarian Response in Oocyte Donors Triggered With GnRH Agonists
Launched by CLÍNICA EUGIN · Oct 27, 2021
Trial Information
Current as of September 28, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Oocyte donors included in the oocyte donation program of Clinica EUGIN that have been triggered with GnRH agonists.
- • Any cycle of oocyte donation from the program of Clinica EUGIN, regardless of the type and dose of gonadotropin used for stimulation.
- Exclusion Criteria:
- • - None.
About Clínica Eugin
Clínica Eugin is a leading fertility clinic dedicated to providing advanced reproductive healthcare services. With a focus on personalized patient care and innovative treatment options, the clinic specializes in assisted reproductive technologies, including in vitro fertilization (IVF) and egg donation. Recognized for its commitment to clinical excellence and research-driven practices, Clínica Eugin aims to enhance the success rates of fertility treatments while ensuring a supportive and compassionate environment for patients. Through ongoing clinical trials and collaborations, the clinic is at the forefront of developing new methodologies that improve outcomes in reproductive medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, Spain
Patients applied
Trial Officials
Anna Blázquez Ventura, MD, PhD
Principal Investigator
Clinica EUGIN
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials